Bibia Heidmann
21Patents
4h-index
16Co-inventors
56Inventor score
Filing activity: Jan 4, 2011 → Jun 11, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9732075B2 | Benzimidazole-proline derivatives | Chemistry; Metallurgy | 7 | Active |
| US9150566B2 | 2-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-YL)picolinamide derivatives as orexin receptor antagonists | Chemistry; Metallurgy | 6 | Active |
| US9493446B2 | Orexin receptor antagonists which are [ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone derivatives | Chemistry; Metallurgy | 5 | Active |
| US9914721B2 | Use of benzimidazole-proline derivatives | Human Necessities | 4 | Active |
| US10065929B2 | Pyrazole compounds and their use as T-type calcium channel blockers | Chemistry; Metallurgy | 4 | Active |
| US9790208B2 | Crystalline salt form of (S)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist | Chemistry; Metallurgy | 4 | Active |
| US10246426B2 | Triazole compounds as T-type calcium channel blockers | Chemistry; Metallurgy | 4 | Active |
| US8895606B2 | Proline sulfonamide derivatives as orexin receptor antagonists | Chemistry; Metallurgy | 4 | Active |
| US9000029B2 | Proline sulfonamide derivatives as orexin receptor antagonists | Chemistry; Metallurgy | 4 | Active |
| US9932314B2 | Pyrazole compounds and their use as T-type calcium channel blockers | Chemistry; Metallurgy | 4 | Active |
| US9914720B2 | Crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[D]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonists | Chemistry; Metallurgy | 3 | Active |
| US10023560B2 | Crystalline salt form of (S)-(2-(6 chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist | Chemistry; Metallurgy | 3 | Active |
| US9242970B2 | Lactam derivatives useful as orexin receptor antagonists | Chemistry; Metallurgy | 3 | Active |
| US9211279B2 | Proline sulfonamide derivatives as orexin receptor antagonists | Chemistry; Metallurgy | 3 | Active |
| US10329287B2 | Benzimidazole-proline derivatives | Chemistry; Metallurgy | 2 | Active |
| US9403813B2 | Azetidine amide derivatives as orexin receptor antagonists | Chemistry; Metallurgy | 1 | Active |
| US11059803B2 | Crystalline form of N-[1-(5-cyano-pyridin-2- ylmethyl)-1H-pyrazol-3-yl]-2-[4-(1-trifluoromethyl-cyclopropyl)-phenyl]-acetamide | Chemistry; Metallurgy | 1 | Active |
| US9303023B2 | Pyrazole and imidazole derivatives useful as orexin antagonists | Chemistry; Metallurgy | 1 | Active |
| US8889688B2 | Piperazines as antimalarial agents | Emerging Cross-Sectional Technologies | 1 | Active |
| US11555025B2 | Crystalline form of N-[1-(5-cyano-pyridin-2-ylmethyl)-1 H-pyrazol-3-yl]-2- [4-(1-trifluoromethyl-cyclopropyl)-phenyl-acetamide | Chemistry; Metallurgy | 0 | Active |
| US11040966B2 | Benzimidazole-proline derivatives | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.